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Higher serum  immunoglobulin (Ig)  levels are  usually observed  in  females more 
than  in males of several  mammalian species,  including man.  Females also show a 
quantitatively and qualitatively enhanced capacity to produce antibodies after im- 
munization  (1-7).  Moreover,  during their  fertile period,  women  have  remarkably 
higher incidences of autoimmune diseases (8, 9). On the other hand, reports exist (10) 
indicating that males have stronger cell-mediated responses than females. These sex- 
dependent differences in the mode and magnitude of immune reactivities are largely 
abolished  by  castration  (11).  A  regulatory  influence  on  the  immune  system  has 
therefore been attributed to the main sex hormones (reviewed in 12). 
The cellular mechanisms involved in the sex hormone-induced immunomodulation 
are yet to be clarified. There are reports (13,  14) indicating that estradiol displays its 
immunoregulatory effect through the thymus, but the relevant cellular target sites for 
sex hormone activity in the immune system are not known. 
We studied the effect of estradiol and testosterone on human blood lymphocytes in 
pokeweed mitogen (PWM)l-stimulated cultures. We found that addition of physio- 
logical concentrations ofestradiol to PWM cultures enhanced the B cell differentiation 
without affecting the proliferative response. This effect was not obtained with testos- 
terone. Cell fractionation studies revealed that estradiol apparently displays its effect 
by inhibiting the activity of a suppressor T  cell population. 
Materials and Methods 
Human  Blood Lymphocytes.  Human  blood  mononuclear  leukocytes were purified  from  the 
buffy coats of 400-ml blood units obtained from healthy male and female volunteers and were 
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l Abbreviations used in this paper:  AET, 2-amino-ethylisothiouronium bromide hydrobromide; ChRBC, 
chicken  erythrocytes;  FCS, fetal calf serum;  FIP, Ficoll-Isopaque, density 1.077; FITC, fluorescein  isothi- 
ocyanate; HBSS, Hanks' balanced salt solution; [aH]TdR, tritiated thymidine; Iclg, intracytoplasmic Ig; 
pA, protein A from Staphylococcus aureus; PBS, 0.1 M NaC1-0.01 M sodium phosphate, pH 7.4; PFC, plaque- 
forming cells; PWM, pokeweed  mitogen; SRBC, sheep erythrocytes;  Ty, T lymphocytes with Fc receptors 
for IgG; T/L, T  lymphocytes with Fc receptors  for IgM; 
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supplied by the Finnish Red Cross Blood Transfusion Service, Helsinki, Finland. The buffy 
coats were diluted with 2 vol of 0.1 M  NaCI-0.01 M  sodium phosphate (PBS), pH 7.4, and the 
mononuclear  cells were  separated  from  granulocytes  and  erythrocytes by  one-step  Ficoll- 
Isopaque (FIP; Pharmacia Fine Chemicals, Div. of Pharmacia, Inc., Uppsala, Sweden; density, 
1.077) gradient centrifugation at 400 g for 40 rain at +22°C  (15). Contaminating erythrocytes 
were lysed by treatment with a Tris-HC1 buffered 0.84%  aqueous solution of NH4CI, pH 7.6 
(Tris-NH4C1). 
Fractionation of Lymphocyte Subpopulations.  The  separation  of T  and  B  cells  and  the  T 
lymphocytes carrying Fc-receptors for IgG (Ty) and IgM (T~)  was modified from Moretta et 
al. (16). FIP-isolated blood leukocytes, depleted from phagocytes by iron powder plus magnet 
treatment,  were  rosetted  with  2-amino-ethylisothiouronium bromide hydrobromide  (AET)- 
treated (17) sheep erythrocytes (SRBC), and the rosetting T cells were separated from the non- 
rosetting B cells by FIP density gradient centrifugation. The B cell-enriched interphase fraction 
contained 75-85% lymphocytes that stained positively for surface Ig with fluorescein isothio- 
cyanate (FITC)-conjugated polyvalent rabbit anti-human Ig (Dako-immunoglobulins, Copen- 
hagen, Denmark). Less than 3% surface Ig-positive cells were found in the T cell-enriched pellet 
fraction. After lysis of the AET-SRBC with Tris-NH4C1, the T  cells -  ~re further enriched for 
Ty and T/z subpopulations by rosetting with rabbit IgG-coated human O  erythrocytes. After 
another centrifugation over FIP, the T),-depleted (T#-enriehed) fraction was recovered from 
the interphase, while the bottom fraction was enriched for Ty cells. 
Lymphocyte Cultures and Quantitation of the Response.  3 ×  105 lymphocytes in 200/11 of RPMI 
1640 tissue culture medium (Gibco Laboratories, Grand Island Biological Co., Grand Island, 
N.  Y.)  supplemented  with  5%  fetal  calf serum  (FCS;  Gibco  Laboratories,  Grand  Island 
Biological Co.) were cultivated in Falcon Microtest II culture tissue plates (Falcon Labware, 
Div.  of Becton,  Dickinson &  Co.,  Oxnard,  Calif.)  for  the  indicated times  in  a  humidified 
atmosphere of 5% CO2 in air. The proliferative responses in mitogen-stimulated cultures were 
quantitated by addition of 0.4 p,  Ci of tritiated thymidine ([3H]TdR,  New England Nuclear, 
Boston, Mass.; specific activity, 6.7 Ci/mmol) per well for 6 h before terminating the cultures 
on the days indicated. To quantitate the different cell types, 104 glutaraldehyde-fixed chicken 
erythrocytes (ChRBC) were added to each culture well before preparation of the cytocentrifuged 
smears (18). Smears from parallel cultures were stained with May-Gri.inwald giemsa (MGG) to 
assess  the  cellular morphology in  each  culture.  To  quantitate  the  number  of plasmablasts 
containing intracytoplasmic immunoglobulin (IcIg), the smears were fixed for  10 min in 3% 
paraformaldehyde at room temperature, washed, and kept in cold (-20°C) acetone for 5 min. 
After rinsing in PBS, the smears were stained with FITC-conjugated 1:30 diluted polyvalent 
anti-human Ig. The number of IcIg-containing ceils was quantitated per 100 autofluorescent 
ChRBC. 
To  quantitate  the  number  of Ig-secreting cells, 5  ×  106  lymphoeytes in  2  ml  5%  FCS 
containing RPMI  1640 medium per well were cultivated in Nunelon macroplates (S. Nunc, 
Roskilde, Denmark), and the response was measured by the reversed protein-A (pA; Pharmacia 
Fine Chemicals)  plaque assay according to Gronowitz et  al.  (19).  Sheep erythrocytes were 
coupled with pA as follows: one part of packed SRBC and one part of pA (0.5 mg/ml) were 
added to ten parts of 2.5 ×  104 M chromium chloride in 0.9% NaCI. The mixture was incubated 
at  30°C  for  1 h  and washed once with  PBS  and  twice with  Hanks' balanced salt solution 
(HBSS). For the plaque assay, 25 pl of 30% pA-coupled SRBC and 25 pl of 1:30 diluted rabbit 
anti-human Ig were incubated at 37°C for 30 min. After incubation, 25 #1 preadsorbed guinea 
pig complement, 100 pl lymphoid cell suspension (0.25  ×  106 to 0.5 ×  10  e eells/ml), and 25 pl 
of HBSS  were  added.  After mixing,  Cunningham  chambers  (20)  were  filled with  the  cell 
suspension, incubated at 37°C for 2 h, and the plaque-forming cells (PFC) were counted in an 
indirect light microscope. 
X-ray Irradiations.  Lymphoid cells were irradiated with a Stabilipan (Siemens AG, Erlangen, 
Federal Republic of Germany) x-ray machine at a dose rate of 711  rad/min. 
Mitogens and Chemicals.  PWM (Gibco Laboratories, Grand Island Biological Co.) was used 
at a final dilution of 1:300. Staphylococcus aureus Cowan I bacteria were used 60 ×  106 organisms/ 
ml. AET was obtained from Sigma Chemical Co., St. Louis, Mo. Stock solutions were prepared 
by dissolving estradiol [ 1,3,4(10)-estratriene-3-17fl-diol] (Makog Chemicals Ltd., Jerusalem, TIMO PAAVONEN, LEIF C.  ANDERSSON, AND HERMAN  ADLERCREUTZ  1937 
Israel)  and testosterone (17/3-hydroxy-4-androsten-3-one) (Steraloids Inc., Wilton, N.  H.)  in 
absolute  ethanol.  For  all  experiments,  the  stock  solutions were  diluted  10-2-10  -4  ,  which 
correspond to 26,000-260 pmol/liter estradiol and 2,000-20 nmol/liter testosterone, respec- 
tively. Physiological estradiol values in fertile women are 100-2,000 pmol/liter, and physiolog- 
ical testosterone values in men are 14-38 nmol/liter. 
Expression of the Results.  Results from the various individual experiments are expressed  as 
the percent of response of otherwise identical parallel control cultures without added hormone 
but containing the same final concentration (0.3%) of ethanol. This concentration of ethanol 
was  nontoxic. When compared  with  parallel  PWM  cultures without  added  ethanol, 0.3% 
ethanol sometimes induced slight but nonsignificant  increase in the proliferative response (<5%) 
and in the generation of Ig-producing cells (<8%). 
Results 
Effect of Testosterone and Estradiol on  T and B  Cell Responses in PWM Cultures.  When 
FIP-isolated blood mononuclear leukocytes from men or women were stimulated with 
PWM  in  the  presence  of  indicated  dilutions of  added  estradiol  or  testosterone, 
significantly increased accumulation of plasmablasts (IcIg) was recorded on days 4-6 
in cultures containing 3  ×  10  -4  (P <  0.05;  Student's t  test)  and  10  -8  (P <  0.005) 
diluted  estradiol.  The  corresponding concentration range  of  testosterone  did  not 
significantly increase or  decrease  the  B  cell  differentiation. The  highest  hormone 
concentrations inhibited the response slightly (Fig.  1 A). 
When cultures were set  up in macroplates and the frequency of Ig-secreting cells 
recorded by the reversed pA-plaque assay on day 6 of culture, an increased number 
of PFC was seen in estradiol-treated cultures when compared with control cultures 
without  added  hormones.  The  peak  response  was  again  obtained  with  hormone 
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FIG.  1.  Iclg-containing ceils (A) and Ig-secreting cells (PFC) (B) on day 6 in PWM-stimulated 
cultures treated with various concentrations of estradiol (shaded columns) or testosterone (open 
columns). Bars indicate SEM of eight different experiments. The control level (100%) represents 
results from PWM cultures without added hormone that gave 30 ×  10  s to 45 ×  10  z Iclg-containing 
cells and 1 ×  l0  s to 2 ×  l0  s PFC/10 ~ Ficoll-Isopaque-purified  blood mononuclear cells. 1938  ESTRADIOL  REGULATES  IN  VITRO  IMMUNE  RESPONSES 
dilutions of 3  ×  10  -4 and  10  -a (P <  0.005).  Again, no significant effect on the PFC 
generation was seen with corresponding dilutions of testosterone (Fig.  1 B). 
To test whether the responsiveness in  PWM cultures to added sex hormones was 
differently expressed in male and female leukocytes, parallel cultures with lymphocytes 
from male and female donors were established, and the IcIg and PFC were measured 
as above. Table I summarizes the results. Both male and female lymphoeytes showed 
the same degree of enhanced B cell differentiation in the presence of added estradiol 
in PWM cultures, whereas testosterone in the dose range used neither stimulated nor 
inhibited  male or  female lymphocytes, as compared with  control  cultures  without 
added hormones. 
The increased generation of plasmablasts in estradiol-treated PWM cultures could 
not  be explained  by an  overall  stimulated  proliferative response.  When  the  DNA 
synthesis was measured by [SH]TdR  incorporation  on  day 3  in  PWM  cultures,  no 
significant differences were seen between estradiol- and testosterone-treated cultures 
and control cultures without added hormone (Table II). The addition of estradiol or 
testosterone in nontoxic concentration did not change the kinetics of the proliferative 
response measured by incorporation of [aH]TdR for 6  h  on the subsequent  culture 
days (days 3-7)  (data not shown). The estradiol-induced increase in the accumulation 
of IcIg and PFC in PWM cultures was not due to an altered kinetics of the response 
pattern.  When  hormone-treated  cultUres  and  control  cultures  were  harvested  on 
TABLE  I 
Effect of Estradiol on IcIg-containing  Cells on Day 6 in PWM-stimulated 
Cultures of Male (M) or Female  (F) Blood Lymphocytes 
Percent of control 
Estradiol 
PFC  IcIg 
dilution 
F1  F2  Mx  M2  Fl  F2  M1  M2 
10  -2  95  84  107  85  90  88  100  106 
3 ×  10  -a  102  92  133  130  151  88  157  143 
10  -a  183  121  183  138  125  184  200  126 
3 ×  10  -4  165  153  200  163  223  131  129  88 
10  -4  130  122  133  94  91  94  114  129 
Control  100  100  100  100  100  100  100  100 
TABLE  II 
Effect of Sex Hormones on DNA Synthesis  on Day 3 in 
PWM-stimulated Cultures 
Hormone dilution 
[3H]Thymidine incorporation* 
Estradiol  Testosterone 
!.0  -2  101  ±  3*  103 ±  3 
3x  10  -a  100±2  101  ±2 
10  -a  102±2  98±2 
3×  10  -4  101  ±3  97±2 
10  -4  96 ±  3  102 ±  3 
* Results are expressed as percent of control cultures without added hormone. 
* Mean ±  SE from ten different experiments. TIMO  PAAVONEN,  LEIF  C.  ANDERSSON,  AND  HERMAN  ADLERCREUTZ  1939 
subsequent days and the number of PFC was recorded, the estradiol-treated cultures 
displayed the peak responses on days 5-6, as did cultures without  added hormone 
(data not shown). 
Hormone Effects on B Cells Producing the Main Ig Classes.  The overall increased B cell 
maturation was recorded with rabbit anti-human polyvalent sera both in the plaque 
assay and  in the fluorescence assay. To identify the cell type(s) responsible for the 
increased B cell maturation in estradiol-treated cultures, the number of cells synthe- 
sizing and excreting the main classes of  human Ig (IgG, IgM, and IgA) was quantitated 
in plaque assays in estradiol-treated and control PWM cultures. As shown in Fig. 2, 
the increased accumulation of differentiated B blasts in estradiol-treated cultures was 
primarily caused by an  increase in  the number of IgM synthesizing and  secreting 
cells, with only slight  (nonsignificant) increases in the accumulation of IgA and IgG 
synthesizing cells. 
Role of Regulatory T  Cells for Estradiol-induced Enhancement of B  Cell Maturation.  To 
study whether the estradiol-mediated effect was transferred via subsets of regulatory 
T  cells, suppressor, and/or helper cells (2 l), T  cell populations carrying Fc-receptors 
for IgG (Ty) and T  cells negative for Fc  7 (T/t) were fractionated from the same buffy 
coat and recombined with an equal number of syngeneic B cells in PWM cultures. 
When B cells were recombined with syngeneic T cells enriched for T7 cells, the typical 
increased accumulation of IgIg-containing cells was seen after addition of estradiol 
(Fig. 3 A). The depletion of the T'}, cells resulted in an overall increased level of IcIg, 
indicating the removal of a  suppressor cell function. Only a  slight  (nonsignificant) 
increase in the response could be obtained after estradiol treatment of such cultures 
(Fig. 3 B). These findings suggested that estradiol inhibited the suppressive activity of 
the T 7 ceils. 
To further investigate the role of T  suppressor cells, the FIP-isolated mononuclear 
cells were x-ray irradiated with 1,000 rad before culture. Such treatment has previously 
been  shown  (21,  22)  to  predominantly  remove the  suppressor  cell  activity.  When 
irradiated cells were stimulated in PWM cultures with or without addition ofestradiol, 
an overall increased frequency of PFC was obtained. No further significant enhance- 
ment was, however, obtained by addition ofestradiol (Fig. 4). These findings indicate 
estradiol influence on a regulatory radiosensitive T  cell population. 
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FIO.  2.  IgA (shaded columns), IgM (filled  columns), and IgG (open columns) secreting PFC on 
day 6 in PWM cultures treated with estradiol. Bars indicate SEM of five different experiments. 1940  ESTRADIOL  REGULATES  IN  VITRO  IMMUNE  RESPONSES 
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FIG.  3.  Iclg-containing cells on day 6  in  PWM-stimulated cultures treated  with various concen- 
trations of estradiol  (shaded columns) or testosterone (open columns). (A)  B cells cultivated with 
syngeneie Ty-enriched T  cells. (B)  B  cells cultivated with T1,-depleted syngeneic T  cells (T/L). (c) 
indicates the increase above the control level (B +  TT) after depletion of Ty cells in the absence of 
added hormone. Bars indicate SEM of three different experiments. 
Does Estradiol Display Its Enhancing Effect Directly on B  Cells?  Because PWM-induced 
B cell maturation is T  cell dependent  (22), the direct influence of estradiol on B cells 
could not be tested with this mitogen. Instead, lymphocytes were stimulated with a T 
cell-independent mitogen, S. aureus Cowan I bacteria (23), in cultures with or without 
added  hormone.  Only a  slight,  nonsignificant  increase in  the accumulation  of PFC 
could be obtained in S. aureus-stimulated cultures treated with estradiol at dilutions of 
3 ×  10  -~ to 3 ×  10  -4 (Table III). 
Discussion 
The  T  cell-dependent  B  lymphocyte differentiation  induced  by  PWM  has  been 
considered  a  model  for  the  humoral  immune  response  (24).  PWM  has  therefore 
received a widespread clinical use for the in vitro functional dissection of the immune 
response to identify subsets of cells responsible for disturbances in the immune system. 
We show that the addition of estradiol significantly increased the accumulation of 
plasmablasts and  Ig-segreting cells in  PWM  cultures of human  blood lymphocytes. 
The  concentrations  of estradiol  giving  the  peak  responses  (780-2,600  pmol/liter) TIMO  PAAVONEN,  LEIF C.  ANDERSSON,  AND  HERMAN  ADLERCREUTZ  1941 
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FIo. 4.  Frequency of PFC on day 6 in PWM-stimulated cultures treated with various concentra- 
tions of estradioL Shaded columns indicate cells x-ray irradiated with 1,000 tad before culture; open 
columns  indicate control  cultures  without  irradiation,  c, effect of irradiation without  estradiol 
treatment. Bars indicate SEM of three different experiments. 
TABLE III 
Effect of Estradiol  on PFC on Day 6 in S. aureus-stimulated  Cultures 
Estradiol dilution  PFC* 
10  -2  113 3= 5~ 
3× 10  -s  114+  12 
10  -a  116 + 2 
3×  10  -4  114:1:4 
10  -4  105 + 3 
* Results are expressed as percent of control cultures without added estradiol. 
:~ Mean :1: SE from three different experiments. 
represent physiological levels and are normally present in fertile female serum during 
late follicular phase before ovulation and in the mid-luted phase (reference values for 
late follicular phase, 350-2,200;  mid-luted phase 300-1,000  pmol/liter; reference 25). 
Corresponding physiological concentration of testosterone did not significantly change 
the PWM-induced B cell differentiation. 
The  FCS  used  contains  detectable  amounts  of  at  least  seven  estrogens.  Gas 
chromatography mass spectrometric  (selected ion monitoring)  assays revealed a  17fl 
estradiol concentration of about 500-600 pmol/liter. Because the same proportion of 
FCS (5%) was used in control and testosterone-treated cultures, a  major influence by 
the sex hormone present in the FCS can be excluded. 
Higher concentrations of either sex hormone were toxic for both the proliferative 
response and the B cell differentiation. This is in agreement with earlier reports (26- 
29), where injection of high doses of estradiol or testosterone to experimental animals 
showed immunosuppressive and thymolytic effects. High doses of sex hormones have 
also been shown  (30, 31)  to suppress the mitogen response of human  T  cells in vitro. 
The enhanced B  cell maturation seen in the presence of physiological concentrations 
of estradiol was not  accompanied by a  significantly increased proliferative response. 
Because  dividing T  cells  are  responsible  for  most  of the  thymidine  incorporation 
during the first days of PWM  cultures (32), this finding argues against an enhancing 
mechanism acting through increased helper T  cell proliferation. The cell fractionation 1942  ESTRADIOL  REGULATES IN  VITRO  IMMUNE  RESPONSES 
studies support this interpretation. When PWM cultures were established by combin- 
ing B cells with syngeneic T  cells depleted for functional suppressor cells either by T 
rosetting or by irradiation,  the overall response measured as PFC increased, but no 
further  significant  enhancement  was  achieved  by  addition  of estradiol.  In  PWM 
cultures  containing  T  cells  enriched  for  functional  suppressor  cells,  the  estradiol 
abrogated  the  suppressive effect.  When  B  cells  were  directly  stimulated  by the  T 
independent  mitogen S.  aureus,  no significant  enhancing  effect of the  PFC  response 
was obtained by addition  of estradiol.  Taking together, these findings indicate that 
estradiol in concentrations of 780-7,850 pmol/liter inhibit the effect of T  suppressor 
cells in  PWM  cultures.  The involvement of T  cell-mediated mechanisms suggested 
here is in agreement with  in  vivo studies  (33,  34)  on the NZB/NZWF  mice, where 
Roubinian  et al. observed that sex hormones modulate the autoimmunity by acting 
on thymus-dependent mechanisms. Stimson and Hunter (13)  recently reported that 
serum  from estradiol-treated  male rats contains  an  immunoregulatory  factor.  This 
factor, which increases the in vitro IgM PFC response of human lymphocytes against 
SRBC,  is not  found  in the serum of rats receiving estradiol after thymectomy (13). 
These observations further support the notion that estradiol displays its immunoreg- 
ulatory activity through the thymus-dependent (T cell) system. 
Estradiol-induced  enhancement  of Ig-synthesis in  PWM cultures on human lym- 
phocytes was mainly caused by an increased differentiation of IgM-producing cells. 
This rather selective effect on the IgM synthesis in vitro is in good agreement with in 
vivo  observations;  women  of  fertile  age  have  higher  serum  IgM  levels  than  do 
postmenopausal women or men (3, 35). The early oral contraceptives, which contained 
high doses of estrogens, have also been found to raise the IgM levels in serum (36).  A 
direct  influence on immunocompetent cells by estradiol  is further indicated  by the 
finding  that  similar effects of estradiol  were obtained  regardless of male vs.  female 
origin of blood leukocytes. 
Interestingly, Lahita  et  al.  (37,  38)  have recently reported  abnormal  patterns  of 
estradiol metabolism in both female and male patients with systemic lupus erythem- 
atosus. These patients display increased  16a hydroxylation of estrogens, leading to an 
accumulation of biologically potent  16a metabolites of estradiol.  These might well 
contribute to the pathogenesis of the disease. 
The expression of functional receptors for estradiol in various types of immunocom- 
petent cells is still incompletely understood. There are reports (14,  39, 40) on surface 
receptors  for sex  hormones  on  lymphocytes and  also  on  the  presence  of estradiol- 
binding receptors in cytosol preparations of rat thymuses. It remains to be established 
whether there are quantitative or qualitative differences in the sex hormone-binding 
structures in various subsets of lymphoid cells in man. 
Our findings indicate that a direct modulating influence on the immunocompetent 
cells  by the  sex  hormones  contribute  to  the  differences  in  immune  responsiveness 
between males and females. The enhancing effect of female sex hormone on the B cell 
maturation might be important for the pathogenesis of various autoimmune disorders. 
Summary 
The effects of the main male and female sex hormones, testosterones and estradiol, 
in pokeweed mitogen (PWM)-stimulated cultures of human blood lymphocytes were 
studied. We found that the addition of physiological concentrations of estradiol (780- TIMO PAAVONEN, LEIF C:. ANDERSSON, AND HERMAN ADLERCREUTZ  1943 
2,600  pmol/liter)  to  PWM  cultures  significantly  increased  the  accumulation  of 
immunoglobulin M-containing and -secreting cells  detected by immunofluorescence 
and/or  by the  reversed  protein-A plaque  assay.  The  dose  range  of estradiol  that 
induced enhanced B cell maturation did not affect the proliferative response. Estradiol 
displayed  the  same  effect  in  vitro  on  lymphocytes  from  both  men  and  women. 
Fractionation of lymphocyte subpopulations before culturing revealed that estradiol 
does not display a direct mitogenic or stimulatory effect on B cells.  Instead, estradiol 
inhibits the suppressive activity of a radio-sensitive (1,000 tad) subset of  T lymphocytes 
bearing Fc-receptors for immunoglobulin G. Nontoxic concentrations of testosterone 
did not influence the in vitro B cell maturation. 
These observations provide a  cellular basis for the differences in the immunoreac- 
tivities of males and  females. The estradiol-induced inhibition of suppressor T  cells 
might be important for the pathogenesis of various autoimmune disorders. 
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